Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Supernus Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Supernus Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Khattar Jack A. | President, CEO | 1,258,351 | Aug 14, 2026 | 12 |
| Rubin Jonathan | SVP, Chief Medical Officer | 13,979 | Aug 14, 2026 | 5 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | 18,637 | Aug 14, 2026 | 8 |
| Mottola Frank | SVP, Chief Tech. Ops. Officer | 19,544 | Aug 14, 2026 | 8 |
| Dec Timothy C | Senior Vice-President & CFO | 9,129 | Aug 14, 2026 | 7 |
| Hudson Frederick M. | Director | 60,413 | Mar 16, 2026 | 4 |
| Horich William Todd | SVP, Commercial Operations | 0 | Mar 10, 2026 | 1 |
| Gemayel Georges | Director | 27,277 | Mar 9, 2026 | 3 |
| Newhall Charles W III | Director | 124,119 | Feb 25, 2026 | 4 |
| Barlow Carrolee | Director | 27,045 | Feb 25, 2026 | 2 |
| Sensenig Bethany | Director | 0 | Feb 23, 2026 | 2 |
| Siebert John M | Director | 87,943 | Feb 27, 2024 | 0 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 86,933 | Feb 27, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 (view filing) | Nov 16 | 4 days | Newhall Charles W IIIDirector | SSale | −2.50K | $28.01 | −$70.0K | −2.1%117.1K after | |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Hudson Frederick M.Director | SSale | −9.09K | $28.50 | −$259.2K | −21.5%33.2K after | 2 lots |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Mottola FrankSVP, Quality, GMP, Ops, IT | SSale | −1.11K | $28.13 | −$31.2K | −16.3%5.68K after | |
| Sep 1, 2023 (view filing) | Aug 30 | 2 days | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −8.10K | $32.00 | −$259.2K | −8.7%85.2K after | |
| Aug 29, 2023 (view filing) | Aug 25 | 4 days | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.13K | $31.59 | −$162.2K | −5.7%85.2K after | |
| Mar 16, 2023 (view filing) | Mar 14 | 2 days | Mottola FrankSr VP, Quality, GMP Oper. & IT | SSale | −4.78K | $35.99 | −$172.0K | −50.2%4.74K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Khattar Jack A.President, CEO | SSale | −13.5K | $42.06 | −$569.2K | −1.7%804.1K after | |
| Feb 6, 2023 (view filing) | Feb 3 | 3 days | Khattar Jack A.President, CEO | SSale | +200 | $42.02 | +$8.40K | 0.0%804.3K after | |
| Feb 3, 2023 (view filing) | Feb 1 | 2 days | Khattar Jack A.President, CEO | SSale | −300 | $42.01 | −$12.6K | 0.0%795.2K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Khattar Jack A.President, CEO | SSale | −976 | $42.01 | −$41.0K | −0.1%795.0K after | |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Khattar Jack A.President, CEO | SSale | −4.94K | $40.40 | −$199.4K | −0.6%794.3K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Bhatt Padmanabh P.Sr. VP of IP, CSO | SSale | −4.83K | $39.92 | −$192.7K | −74.6%1.64K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Khattar Jack A.President, CEO | SSale | −25.4K | $40.03 | −$1.02M | −3.1%791.2K after | |
| Jan 9, 2023 (view filing) | Jan 6 | 3 days | Bhatt Padmanabh P.Sr. VP of IP, CSO | SSale | −174 | $39.90 | −$6.94K | −9.6%1.64K after | |
| Dec 22, 2022 (view filing) | Dec 20-21 | 2 days | Khattar Jack A.President, CEO | SSale | −15.4K | $38.11 | −$585.3K | −1.9%814.7K after | 2 lots |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Bhatt Padmanabh P.Sr. VP of IP, CSO | SSale | −5.00K | $37.48 | −$187.4K | −75.3%1.64K after | |
| Nov 28, 2022 (view filing) | Nov 23-25 | 5 days | Khattar Jack A.President, CEO | SSale | −13.4K | $35.16 | −$470.9K | −1.7%789.4K after | 2 lots |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Khattar Jack A.President, CEO | SSale | −600 | $35.00 | −$21.0K | −0.1%781.4K after | |
| Nov 22, 2022 (view filing) | Nov 21 | 1 day | Khattar Jack A.President, CEO | SSale | −531 | $35.01 | −$18.6K | −0.1%781.1K after | |
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | Khattar Jack A.President, CEO | SSale | −1.11K | $35.00 | −$39.0K | −0.1%780.7K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Bhatt Padmanabh P.Sr. VP of IP, CSO | SSale | −6.80K | $34.95 | −$237.7K | −80.5%1.64K after | |
| Nov 14, 2022 (view filing) | Nov 9 | 5 days | Bhatt Padmanabh P.Sr. VP of IP, CSO | SSale | −700 | $34.97 | −$24.5K | −29.9%1.64K after | |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.00K | $35.98 | −$179.9K | −5.4%87.2K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Khattar Jack A.President, CEO | SSale | −14.7K | $34.01 | −$499.6K | −1.9%775.6K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Khattar Jack A.President, CEO | SSale | −17.3K | $34.03 | −$588.8K | −2.2%759.9K after | |
| Aug 11, 2022 (view filing) | Aug 10 | 1 day | Khattar Jack A.President, CEO | SSale | −28.4K | $31.22 | −$887.8K | −3.7%741.4K after | |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Khattar Jack A.President, CEO | SSale | −39.4K | $31.15 | −$1.23M | −5.2%725.0K after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Khattar Jack A.President, CEO | SSale | −117.9K | $31.46 | −$3.71M | −14.4%701.3K after | 2 lots |
| Aug 5, 2022 (view filing) | Aug 4 | 1 day | Martin Tami TillotsonSr. V.P., Regulatory Affairs | SSale | −5.00K | $32.98 | −$164.9K | −5.4%87.2K after |